DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Solara Active Pharma Sciences Limited — Board Meeting Intimation

NSE 1 hr ago·9 Oct 2026, 11:06 am

Solara Active PHA SCI

Solara Active Pharma Sciences has announced that its board will meet on October 16, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026. This scheduled meeting is a standard corporate procedure used to assess the company's current financial performance.

For investors, this update is important as it provides an early glimpse into Solara's operational health and profitability. The results will offer insights into how the company is managing its business during this period and may influence market sentiment ahead of the official release.

Investors should watch for the specific details on revenue growth and operational margins when the results are finally declared. Keeping an eye on management commentary regarding future business prospects will also be key to understanding the stock's short-term trajectory.